Aclaris Therapeutics, Inc. (ACRS)
3.83
+0.04
(+1.06%)
USD |
NASDAQ |
Oct 09, 16:00
3.825
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Cash and Short Term Investments (Quarterly) : 91.56M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 91.56M |
| March 31, 2026 | 105.42M |
| December 31, 2025 | 90.75M |
| September 30, 2025 | 95.91M |
| June 30, 2025 | 99.81M |
| March 31, 2025 | 105.31M |
| December 31, 2024 | 113.59M |
| September 30, 2024 | 127.72M |
| June 30, 2024 | 111.09M |
| March 31, 2024 | 128.17M |
| December 31, 2023 | 119.11M |
| September 30, 2023 | 103.05M |
| June 30, 2023 | 119.78M |
| March 31, 2023 | 170.80M |
| December 31, 2022 | 217.57M |
| September 30, 2022 | 248.06M |
| June 30, 2022 | 248.60M |
| March 31, 2022 | 179.62M |
| December 31, 2021 | 191.41M |
| September 30, 2021 | 197.88M |
| June 30, 2021 | 231.67M |
| March 31, 2021 | 128.30M |
| Date | Value |
|---|---|
| December 31, 2020 | 54.13M |
| September 30, 2020 | 55.23M |
| June 30, 2020 | 68.12M |
| March 31, 2020 | 79.00M |
| December 31, 2019 | 75.02M |
| September 30, 2019 | 91.43M |
| June 30, 2019 | 115.52M |
| March 31, 2019 | 136.76M |
| December 31, 2018 | 167.97M |
| September 30, 2018 | 134.27M |
| June 30, 2018 | 164.60M |
| March 31, 2018 | 186.98M |
| December 31, 2017 | 193.86M |
| September 30, 2017 | 227.85M |
| June 30, 2017 | 170.50M |
| March 31, 2017 | 153.42M |
| December 31, 2016 | 137.22M |
| September 30, 2016 | 84.04M |
| June 30, 2016 | 94.01M |
| March 31, 2016 | 85.25M |
| December 31, 2015 | 84.87M |
| September 30, 2015 | 38.40M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 308.20M |
| Alumis, Inc. | 502.29M |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Veru, Inc. | 25.79M |
| Johnson & Johnson | 20.76B |